SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?


To: HeyRainier who wrote (1181)6/26/1998 12:10:00 PM
From: Sylvester  Read Replies (1) | Respond to of 4140
 
Rainer,

It's not enough to say I agree with your comment. I am consistantly amazed about how your charts reflect the true market situation.

the only thing out there with no news that influences this stock today is the eventual NASDAQ listing. Followers of this thread and maybe even the YAHOO thread have seen several "knowledgeable" predictions (none from me) on the listing date. Since our friend Cubby is one of these, it can be traced to the information or misinformation supplied directly by Sunrise.

Even if you didn't have a chart, what would this cause? Answer - indecision.

Why isn't the volume greater? Mostly Doctors and committed investors own the stock. (other than SNRS directors)

Investors, even those with grandiose dreams should be happy with their profits to this point and now it's time that causing them concern. Some are selling, and others, as your charts indicate, are ready to fall off the fence if the price breaches $7. It's logical and it's smart. Plenty of interesting things to invest in out there.

Doctors, many own this stock real low, but want to sell at a price high enough to buy one or more lasers when they become available. They are in for the long haul. They can't lose if they were in early (most were) and in fact, this still is a good plan. You can expect FDA approval and a 300% jump from today's price to coincide. (Actually the plan is to sell half and keep the rest).

Delays won't bother them either, because FDA delayed decisions are approved over 90% of the time.

Some Doctors may trade the stock, but those I'm in touch with aren't likely to play with a significant amount of their holdings.

Those who realize that a few small shareholders can greatly effect the price, must also consider that downtrends stimulated in this fashion are short term as these are considered buying opportunities for long termers. Lacking any bad news, or news at all, we would still see much higher buying volume at $6, then selling volume.

If your looking for 300% in 24 months, you stay where you are.

Logic suggests that the "missed" NASDAQ deadline (which was fictional anyway) is the reason for weakness. There's also a large percentage of stockholders who are afraid to sell just in case, and wait until tomorrow, and tomorrow, and tomorrow.

The proportion of sellers because we missed NASDAQ, to those holders or even buyers because they've first heard the rumer or they won't sell at this price is becoming lower.

Those facing forward and buying into the story are doing so much more cautously and in less volume. But their numbers increase.

I think that confidence in a listing next month is becoming more of a factor every day, and if this is true, you should see less indecision and small increases on slightly increasing volume in the near term.

If nothing changes by mid July, a reversal of fortune is likely.

That's just my considered opinion based largely on what I hear, and what your projections indicate to me.

Sincerely,

Sylvester

Loren, we look forward to your next update.